Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
Vascularized composite allotransplantations (VCAs) are not routinely performed for tissue reconstruction because of the potentially harmful adverse effects associated with lifelong administration of immunosuppressive agents. Researchers have been eagerly seeking alternative methods that circumvent t...
Saved in:
Main Authors: | Yur-Ren Kuo, Chien-Chang Chen, Shigeru Goto, Pao-Yuan Lin, Fu-Chan Wei, Chao-Long Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/854846 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Need for Inducing Tolerance in Vascularized Composite Allotransplantation
by: Kadiyala V. Ravindra, et al.
Published: (2012-01-01) -
Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential
by: Jonas T. Schnider, et al.
Published: (2013-01-01) -
Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
by: Ravi Starzl, et al.
Published: (2013-01-01) -
Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation
by: Ricardo Londono, et al.
Published: (2016-01-01) -
Mechanisms and Mediators of Inflammation: Potential Models for Skin Rejection and Targeted Therapy in Vascularized Composite Allotransplantation
by: Theresa Hautz, et al.
Published: (2012-01-01)